Login

Kuvera co-founder Neelabh Sanyal invests 80% of his portfolio in equities through index funds.|Gaurav Rastogi is the CEO of Kuvera 00:10:00

Share On Facebook Share On Twitter

Gaurav Rastogi is the CEO of Kuvera

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Overview of Junior ASX-listed Coking Coal Producer's Operations and Projects"
00:10:00
ASX 200 Insights with WAM Leaders Investment Team: Anna Milne and Hailey Kim
00:10:00
A short version of the Tiko ICT TOC 2022 interview.|Karim Henkens Chief Executive Officer of ICT Group
00:10:00
NovaGold: Advancing Donlin Gold Project with Strong Financials and Federal Permits
00:10:00
Luciano Alves, CFO of CBA, Discusses Investor Sentiment, Global Slowdown, and ESG Priorities | Luciano Alves, CEO , Companhia Brasileira de Alumínio.
00:10:00
What to Look for in a Financial Advisor
00:10:00
Advancements in Hydrogen Technology: A Look at Major Projects and Market Impact with Damien Havard | Damien Havard, CEO,Hydrogene De France SA.
00:10:00
A Business Founded on a Simple and Powerful Model|Kenneth M. Jacobs,Executive Chairman,Lazard Group LLC
00:10:00
Preparing Goldman Sachs for Economic Uncertainty | David Solomon, CEO,  Goldman Sachs.
00:10:00
Globe Telecom CEO Ernest Cu discusses G-Cash.
00:10:00
Biopharmaceutical company focused on the development and commercialization of firstinclass critical care products|Myron Holubiak,CEO,Citius Pharmaceuticals
00:10:00
"Global Leadership in Asset Management: Insights from Laurence D. Fink of BlackRock | Laurence D. Fink - Chairman & CEO, BlackRock, Inc."

© 2026 Nehu